Going Public and to free up affiliate shares into free trading shares
Description
Pharmaceutical Resource Technology, Inc. is a Wyoming C Corp operating in the food, pharmaceutical and construction industry in Singapore. We are authorized to issue up to 3,000,000,000 common stocks. Our current outstanding stock is 2,790,914,515 but is increasing as a fund raising campaign is ongoing under Rule 504 of the Regulation D to raise USD10M through the sale of 20,000,000 common stock for USD0.50/common stock to implement a protected business expansion into Thailand.
We are currently preparing to go public on OTCQB with tradeable stock on the OTC Market group. However, to qualify for OTCQB, 10% of the outstanding stock must be free trading. Our affiliates are holding 2,684,287,200 common from the outstanding. These stocks are no longer restricted under rule 144 as they are issued in 2020. We are looking at selling off 15% of these affiliate stocks (about 400,000,000) at USD0.10/stock (negotiable). Minimum purchase for the stock is 1,000,000 stocks. Our stock record is kept with Colonial Stock Transfer Company. Our Financial Statements, 2023 and 2024 are audited by PCAOB registered firm. Our CIK and CUSCIP code are all available.
Business Operation
The company has a tangible and intangible assets of more than USD31million.
Facilities
Company has filed for Regulation D to raise USD10M for business expansion into South East Asia region.
Singapore 
